Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 651 to 675 of about 5889

Previous 25

Website Changes

07/27/2021

Brain tumour patients and COVID-19 vaccines: IBTA international survey

07/26/2021

Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis

07/26/2021

Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

07/26/2021

COMBINATION OF TUMOR TREATING FIELDS (TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

07/24/2021

A genetic mutation causing DMG and a potential drug to treat it

07/21/2021

KIYATEC Marks Glioblastoma Awareness Day by Initiating Use of 3D Predict™ Glioma Test Outside of Clinical Study

07/17/2021

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

07/10/2021

Nivolumab Plus Standard- or Reduced-Dosed Bevacizumab for Recurrent Glioblastoma

07/09/2021

Musella Foundation awards two brain tumor research grants!

07/06/2021

Prolonged survival after laser interstitial thermal therapy in glioblastoma

07/06/2021

Kansas advocate for brain cancer patients dies at 22 after giving voice to sick kids

07/03/2021

Virtualtrials.org website update

07/03/2021

Updated most of the survivor stories!

06/29/2021

Safety and Efficacy of Vorasidenib in Recurrent or Progressive Glioma

06/25/2021

Adjuvant—Not Concurrent—Temozolomide Upped Overall Survival in 1p/19q Non–Co-Deleted Anaplastic Glioma: Commentary on the CATNON Trial

06/24/2021

First Glioblastoma Patient Treated in Focused Ultrasound Clinical Trial at University of Virginia

06/24/2021

Musella Foundation Copay Assistance Program is now open!

06/20/2021

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

06/19/2021

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational brain cancer registry

06/17/2021

Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay

06/17/2021

Costly brain cancer drug no longer covered by Medicare

06/14/2021

Save the Date! Promo Discount Code for National Walk To End Brain Tumors: Clark, NJ 7/24/21

06/14/2021

Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma

06/11/2021

Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma

06/10/2021

Promising New Legislation Could Transform the FDA`s Drug Approval Process, Leading to Better Treatments and Lower Prices

Our privacy / cookie policy has changed.
Click HERE to read it!